California Public Employees Retirement System’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,950
Closed -$714K 1890
2021
Q1
$714K Sell
1,950
-175
-8% -$72K ﹤0.01% 2734
2020
Q4
$797K Sell
2,125
-108
-5% -$43.2K ﹤0.01% 2634
2020
Q3
$1.01M Buy
2,233
+120
+6% +$69.1K ﹤0.01% 2281
2020
Q2
$1.55M Buy
2,113
+1,646
+352% +$1.19M ﹤0.01% 1939
2020
Q1
$199K Hold
467
﹤0.01% 2848
2019
Q4
$222K Buy
+467
New +$147K ﹤0.01% 3074

Other funds holding CUE

California Public Employees Retirement System's CUE Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Cue Biopharma (CUE) in Q2 2021, closing a stake of 1,950 shares — an estimated $714K sold.

California Public Employees Retirement System first reported a position in CUE in Q4 2019 and held it in 6 quarters. The position peaked at $1.55M in Q2 2020. 89 funds tracked by Wall St. Rank hold CUE as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Cue Biopharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 1,950 Cue Biopharma shares in Q2 2021, an estimated $714K.
  • California Public Employees Retirement System first reported a position in Cue Biopharma in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Cue Biopharma position peaked at $1.55M in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.